Skip to content

Swallowing Rehabilitation Program for Head and Neck Tumor Patients

Evaluation of a Structured Swallowing Rehabilitation Exercise Program on Dysphagia and Trismus in Head and Neck Tumor Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07795294
Acronym
SREP-HNC
Enrollment
80
Registered
2026-08-31
Start date
2026-08-31
Completion date
2027-06-25
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer (H&N)

Keywords

Dysphagia, Trismus, Swallowing Rehabilitation, Deglutition Disorders, Head and Neck Cancer, EAT-10, Gothenburg Trismus Questionnaire

Brief summary

This study aims to evaluate the effect of a structured swallowing rehabilitation program on swallowing function, trismus severity, and pain among patients with head and neck tumors, using a randomized controlled trial design. Eighty patients will be randomly allocated into two equal groups: a study group receiving the swallowing rehabilitation program and a control group receiving standard care.

Detailed description

The swallowing rehabilitation program is a structured intervention designed to improve swallowing ability, mouth opening, and jaw mobility in patients with head and neck tumors. It includes the Mendelsohn maneuver, effortful swallow, Masako technique, tongue strengthening, and jaw range-of-motion and stretching exercises, performed as three sets of ten repetitions twice daily. The program is delivered across four phases (assessment, planning, implementation, and evaluation) over structured orientation, theoretical, and practical sessions. Outcomes are assessed using the EAT-10 (swallowing function) and the Gothenburg Trismus Questionnaire 2 / GTQ2 (trismus severity), in addition to pain level, at baseline and 6 weeks after initiation of the program.

Interventions

BEHAVIORALSwallowing Rehabilitation Program

A structured program including Mendelsohn maneuver, effortful swallow, Masako technique, tongue strengthening exercises, and jaw range-of-motion and stretching exercises, performed as three sets of ten repetitions twice daily, delivered through orientation, theoretical, and practical sessions.

Sponsors

Delta University for Science and Technology
Lead SponsorOTHER
National Cancer Institute, Cairo
CollaboratorOTHER
Clinical Oncology department. Elmansoura University.
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Both genders * Aged 20-60 years * Patients receiving chemoradiotherapy * Patients having a history of head and neck cancer * Patients who had received previous radiation therapy for head and neck cancer

Exclusion criteria

* Patients who had neurological or psychiatric problems * Patients who had dysphagia for a reason other than cancer

Design outcomes

Primary

MeasureTime frameDescription
Change in Swallowing Function as Measured by the Eating Assessment Tool-10 (EAT-10)Baseline and 6 weeks after initiation of the swallowing rehabilitation programSwallowing function assessed using the Eating Assessment Tool-10 (EAT-10), a 10-item self-administered questionnaire with total scores ranging from 0 to 40, with higher scores indicating greater swallowing difficulty (0-3 = normal swallowing, ≥4 = possible dysphagia, 10-20 = moderate dysphagia, \>20 = severe dysphagia).

Secondary

MeasureTime frameDescription
Change in Trismus Severity as Measured by the Gothenburg Trismus Questionnaire 2 (GTQ-2)Baseline and 6 weeks after initiation of the swallowing rehabilitation programTrismus severity assessed using the Gothenburg Trismus Questionnaire 2 (GTQ-2), a 20-item questionnaire with total scores ranging from 24 to 120, with higher scores indicating greater trismus severity (24 = no trismus, 25-57 = mild, 58-89 = moderate, 90-120 = severe trismus).

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 1, 2026